US2011021637A1PendingUtilityA1

Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment

Assignee: METAPROTEOMICS LLCPriority: Jun 20, 2001Filed: Apr 6, 2010Published: Jan 27, 2011
Est. expiryJun 20, 2021(expired)· nominal 20-yr term from priority
A61K 36/53A61P 35/00A61K 31/12A61K 31/122A61K 36/3486
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, or tetrahydro-isoalpha acids commonly found in hops.

Claims

exact text as granted — not AI-modified
1 . A composition to treat a cancer responsive to protein kinase modulation in a mammal in need thereof, said composition comprising a therapeutically effective amount of a chalcone and a tetrahydro-isoalpha acid (THIAA); wherein said therapeutically effective amount modulates a cancer associated protein kinase. 
     
     
         2 . The composition of  claim 1 , wherein the chalcone is xanthohumol or isoxanthohumol. 
     
     
         3 . The composition of  claim 1 , wherein the composition further comprises a pharmaceutically acceptable excipient selected from the group consisting of coatings, isotonic and absorption delaying agents, binders, adhesives, lubricants, disintergrants, coloring agents, flavoring agents, sweetening agents, absorbants, detergents, and emulsifying agents. 
     
     
         4 . The composition of  claim 1 , wherein the composition further comprises one or more members selected from the group consisting of antioxidants, vitamins, minerals, proteins, fats, and carbohydrates. 
     
     
         5 . The composition of  claim 1 , wherein the tetrahydro-isoalpha acid is selected from the group consisting of tetrahydro-isohumulone, tetrahydro-isocohumulone, and tetrahydro-adhumulone. 
     
     
         6 . The composition of  claim 1 , wherein the composition further comprises a pharmaceutically acceptable excipient selected from the group consisting of coatings, isotonic and absorption delaying agents, binders, adhesives, lubricants, disintergrants, coloring agents, flavoring agents, sweetening agents, absorbants, detergents, and emulsifying agents. 
     
     
         7 . The composition of  claim 1 , wherein the composition further comprises one or more members selected from the group consisting of antioxidants, vitamins, minerals, proteins, fats, and carbohydrates.

Join the waitlist — get patent alerts

Track US2011021637A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.